GHRP's vs GHRH's

Tesamorelin. Ipamorelin. Hexamorelin. Sermorelin. CJC-1295. Do You Actually Know the Difference?

You've heard of these as GH peptides. But most people using them, or considering using them, cannot explain the fundamental difference between the two categories they fall into: GHRHs and GHRPs.

That distinction matters. Because the category determines the mechanism, and the mechanism determines the result.

How Your Body Controls GH Output

Your pituitary gland releases growth hormone, but it does not decide when on its own.

It receives two opposing signals from the hypothalamus: GHRH tells it to release GH, and somatostatin tells it to stop. Think of GHRH as the gas pedal and somatostatin as the brake. The balance between the two determines your GH output, which is always released in pulses, not a constant stream.

Ghrelin, a hormone produced in your stomach, acts as a third signal. It works through a completely separate receptor and intervenes at two points simultaneously: at the hypothalamus it amplifies GHRH output and suppresses somatostatin, and at the pituitary it directly triggers GH release without needing any signal from the hypothalamus at all.

This is the system that GHRHs and GHRPs are both targeting, just from completely different angles.

What GHRHs Do

GHRHs work by mimicking the GHRH signal from the hypothalamus. They act directly on the pituitary through the same receptor the hypothalamus uses naturally, stimulating GH release. That is their only point of action. They push the gas pedal. They do not touch somatostatin. The brake stays fully active.

Because the brake remains untouched, GHRH effectiveness is dependent on the somatostatin environment at the time of injection. If somatostatin is running high, the response gets blunted. This is why timing and fasting state matter significantly with this category. A fasted state, lower blood glucose, and injecting away from meals all reduce somatostatin tone and improve the response.

Within GHRHs, the key variable is half-life. Short-acting versions clear quickly, allowing the GHRH receptor to reset between doses and preserving the natural pulsatile GH rhythm your body is designed to run on. Longer-acting versions produce a sustained, flat GH elevation instead of distinct pulses. That continuous stimulation can desensitize the receptor over time, blunting your response and reducing the effectiveness of the compound.

One point of action. Half-life is the variable that matters most.

What GHRPs Do

GHRPs work by mimicking ghrelin. They operate through a completely separate receptor system and hit three points simultaneously: they increase GHRH output from the hypothalamus to the pituitary, decrease somatostatin output from the hypothalamus to the pituitary, and act directly on the pituitary itself to stimulate GH production. Three points of action versus one.

Because somatostatin suppression is built into their mechanism, GHRPs are not dependent on the hormonal environment at the time of injection the way GHRHs are. The response is more consistent and produces a faster GH pulse, typically peaking within 15 to 30 minutes compared to the 30 to 60 minute window seen with GHRHs.

GHRPs also maintain your natural pulsatile rhythm. Every dose produces one amplified GH pulse and then clears. They increase how large the pulse is, not how long GH stays elevated. This makes them fundamentally different in character from the longer-acting GHRHs, which trade pulse size for duration.

Within GHRPs, the key variable is selectivity. Some compounds raise GH cleanly with minimal effect on cortisol and prolactin. Others produce a stronger GH pulse but elevate those hormones alongside it. The tradeoff between potency and selectivity is the defining variable within this category, and it is what separates the individual compounds from one another.

Three points of action. Selectivity is the variable that matters most.

The Core Difference

GHRHs push the gas pedal through one pathway and leave the brake completely untouched. GHRPs push the gas through a different pathway, remove the brake, and stimulate the pituitary directly.

That is why the two categories are not interchangeable. Choosing between them, or combining them, depends on understanding exactly what each one is doing inside the system and what you are trying to accomplish.